Results 21 to 30 of about 306,697 (259)

Characteristics of RCTs.

, 2019
Characteristics of RCTs.
Masanori Kawano (798368), Ichiro Itonaga (798369), Kazuhiro Tanaka (434060), Tatsuya Iwasaki (798370), Hiroshi Tsumura (798371)   +4 more
core   +1 more source

The characteristics of included RCTs.

, 2022
The characteristics of included RCTs.
Shuyuan Gan (12410397), Yang Yu (4292), Yongxing Yao (14279157), Xianhui Kang (10020791), Xiuzhen Lei (12551418), Mei Li (217363), Yanfeng Zhou (644914), Peng Fang (305417)   +7 more
core   +1 more source

Phenotypic divergence in rotator cuff tear and volumetric muscle loss mouse models following fibroadipogenic progenitor depletion

Bone & Joint Research
Aims: Fibroadipogenic progenitors (FAPs) are a group of resident muscle stem cells capable of differentiating into fibroblasts and adipocytes, contributing to intramuscular fibrotic and fatty degeneration after injury.
Zili Wang, Luke Sang, Alex Youn, Mengyao Liu, Brian T. Feeley, Xuhui Liu   +5 more
doaj   +1 more source

Medical complications for RCTs.

, 2016
Medical complications for RCTs.
A. Sedrakyan (2833064), H. J. L. van der Heide (2833079), J. M. T. A. Meessen (2833061), R. G. H. H. Nelissen (2833076), J. W. Schoones (2833067), M. Fiocco (2833070), B. G. Pijls (2833073)   +6 more
core   +1 more source

Main characteristics of included RCTs.

, 2021
Main characteristics of included RCTs.
Gustavo Nader Marta (6746570), Camila Bertini Martins (7142774), Orestis Efthimiou (5489792), Rachel Riera (4704601), Carolina de Oliveira Cruz Latorraca (10264879), Suely Maymone de Melo (11648998)   +5 more
core   +1 more source

Doing trials within trials: a qualitative study of stakeholder views on barriers and facilitators to the routine adoption of methodology research in clinical trials

Trials, 2018
Background Randomised controlled trials are the cornerstone of evidence-based health care, yet many trials struggle with recruitment and retention. All too often the methodologies employed to address these problems are not evidence-based, as rigorous ...
Jo Rick, Mike Clarke, Alan A. Montgomery, Paul Brocklehurst, Rachel Evans, Peter Bower   +5 more
doaj   +1 more source

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source

Fracture Risk Associated With Long‐Term Discontinuation of Postmenopausal Osteoporosis Treatment: A French Population‐Based Study Using National Claims Data (Système National des Données de Santé)

ACR Open Rheumatology
Objective This retrospective cohort study evaluated the long‐term discontinuation (LTD) of osteoporosis treatments in postmenopausal women in France and associated fracture risk and economic burden.
Audrey Lajoinie, Meriem Benmerad, Magali Laborey, Pascale Samama, Gaëlle Désaméricq, Leila Chelbani, Karine Briot   +6 more
doaj   +1 more source

Quality of included RCTs.

, 2016
Quality of included RCTs.
Xiao-Li Wu (495744), Bin-Jiao Wu (3202422), Xi-Xi He (3202416), Zhi-Ming Huang (755481), Chao Chen (195669), Ren-Pin Chen (3202419), Xiao-Gang Liu (213598)   +6 more
core   +1 more source

Microfinance RCTs in Development

, 2020
Microcredit has long stood as a flagship topic for RCTs in development, starting with the publication of a special issue in a leading economics journal on six RCTs conducted in different world regions.
Isabelle Guérin, Roubaud, François, Guérin, Isabelle, Bédécarrats, F., Florent Bédécarrats, François Roubaud   +5 more
core   +1 more source